Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

R-ketamine Demonstrates Tolerability in Phase 1 Single Ascending Dose Study

americanpharmaceuticalreviewFebruary 24, 2021

Tag: PCN-101 , R-ketamine , depression , S-ketamine

PharmaSources Customer Service